Showing results (81-90 of 98) with videos related to

Sort By:
Pageof 10
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2019
The Nanocind Signature Is an Independent Prognosticator of Recurrence and Death in Uterine LeiomyosarcomasSabrina Croce, Tom Lesluyes, Carine Valle, et al.
Bulletin Du Cancer|April 12, 2023
[Treatments for rare ovarian tumors: What's new?]Coriolan Lebreton, Stanislas Quesada, Marta Bini, et al.
Nucleic Acids Research|February 14, 2019
Modulation of the ATM/autophagy pathway by a G-quadruplex ligand tips the balance between senescence and apoptosis in cancer cellsJennifer Beauvarlet, Paul Bensadoun, Elodie Darbo, et al.
Acta Neuropathologica Communications|May 7, 2026
Ovarian central nervous system-type tumors: integrated neuropathological and methylation-based classification reveals site-related featuresMartin Raby, Alexis Trécourt, Euphrasie Servant, et al.
Genes, Chromosomes & Cancer|October 24, 2018
GREB1-CTNNB1 fusion transcript detected by RNA-sequencing in a uterine tumor resembling ovarian sex cord tumor (UTROSCT): A novel CTNNB1 rearrangementSabrina Croce, Tom Lesluyes, Lucile Delespaul, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 2, 2015
Uterine smooth muscle tumor analysis by comparative genomic hybridization: a useful diagnostic tool in challenging lesionsSabrina Croce, Agnes Ribeiro, Celine Brulard, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|July 2, 2025
Deep Learning Can Accurately Predict the Prognosis of Gynecologic Smooth Muscle Tumors of Uncertain Malignant Potential: A Multicenter Pilot StudyJoão Costa, Van-Linh Le, Antonio De Leo, et al.
Bulletin Du Cancer|October 8, 2023
[Diagnosis of uterine sarcomas and rare uterine mesenchymal tumours with malignant potential. Guidelines of the French Sarcoma Group and Rare Gynaecological Tumours]Sabrina Croce, Mojgan Devouassoux-Shisheboran, Patricia Pautier, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 14, 2023
High-Grade Endometrial Stromal Sarcomas With YWHAE::NUTM2 Gene Fusion Exhibit Recurrent CDKN2A Alterations and Absence of p16 Staining is a Poor Prognostic MarkerFelix K F Kommoss, Lisa-Marie Mar, Brooke E Howitt, et al.
Histopathology|August 12, 2025
Endometrial carcinoma and immune escape: prognostic relevance of HLA class I loss in NSMP subtypeMarco Grillini, Jacopo Lenzi, Claudio Ceccarelli, et al.
Pageof 10